GGrantIndex
Sort

326,823 grants matching clinical trial

Vaccine strategies for HIVAIDS

$2,867,414
Jay A Berzofsky · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

Bioengineered Antibodies in Cancer Imaging and Therapy

$2,865,482
City Of Hope/Beckman Research Institute · P01 · FY2005 · CA

Pragmatic Trial of Acupuncture for Chronic Low Back Pain in Older Adults

$2,864,772
Karen J Sherman · Kaiser Foundation Research Institute · UH3 · FY2021 · AT

Data Acquisition and Analysis Core

$2,864,255
Sara Jane Webb · Yale University · U19 · FY2018 · MH

UZ-UCSF CTU

$2,864,034
Zvavahera Mike Chirenje · University Of California, San Francisco · UM1 · FY2025 · AI

Novel antibacterial agents for treatment of Tularemia

$2,864,024
Affinium Pharmaceuticals, Inc. · U01 · FY2003 · AI

Admin Core

$2,863,988
James J. Dignam · University Of Chicago · U10 · FY2021 · CA

Immunologic and virologic determinants of congenital Cytomegalovirus transmission and disease in rhesus monkeys

$2,863,852
Sallie R. Permar · Duke University · P01 · FY2019 · AI

NIH StrokeNet National Clinical Coordinating Center (NCC)

$2,863,371
Pooja Khatri · University Of Cincinnati · U01 · FY2024 · NS

Vanderbilt-West Virginia (VWV) Collaborative: A HOPE Consortium Clinical Center

$2,863,288
Kerri Cavanaugh · Vanderbilt University Medical Center · U01 · FY2019 · DK

Enhancing Chimeric Antigen Receptor T Cell Therapies for HematologicMalignancies: Beyond CART 19

$2,863,199
Carl H. June · University Of Pennsylvania · P01 · FY2025 · CA

Program Project in Models of Breast Cancer

$2,863,125
Larry Norton · Sloan-Kettering Inst Can Research · P01 · FY2008 · CA

Medical Oncology Service Clinical Core

$2,862,970
James L. Gulley · Division Of Basic Sciences - Nci · ZID · FY2020 · CA

Vaccine and Treatment Evaluation Unit:Phase II Pertussis Vaccine Trial

$2,862,677
Michelle Medeiros · University Of Maryland Baltimore · N01 · FY2017 · AI

BRIDGE TRIAL

$2,862,492
Thomas L Ortel · Duke University · U01 · FY2014 · HL

Morehouse School of Medicine G12 Multidisciplinary Biomedical Research Center

$2,862,414
Vincent C Bond · Morehouse School Of Medicine · G12 · FY2016 · MD

Comparing Treatment Approaches to Promote Inpatient Rehabilitation Effectiveness for Traumatic Brain Injury (CARE 4 TBI)

$2,862,193
Jennifer A Bogner · Ohio State University · UH3 · FY2023 · NS

Comparison of Anti-coagulation and anti-Platelet Therapies for Intracranial Vascular Atherostenosis

$2,862,143
Brian Lim Hoh · University Of Florida · U01 · FY2024 · NS

Molecular Therapeutics of Kidney Cancer: VHL Gene and Fumarate Hydratase Gene

$2,861,642
William Marston Linehan · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA

HIV-1 Vaccine Based on Chimp Serotypes of Adenovirus

$2,861,413
Hildegund C. J. Ertl · Wistar Institute · U19 · FY2008 · AI

AAA Disease: Mechanism, Stratification and Treatment

$2,860,642
Ronald L Dalman · Stanford University · P50 · FY2006 · HL

Center for Adolescent Reward, Rhythms and Sleep (CARRS)

$2,860,596
Colleen A McClung · University Of Pittsburgh At Pittsburgh · P50 · FY2025 · DA

Drug Repurposing Screening for Rare and Neglected Diseases

$2,859,284
Wei Zheng · National Center For Advancing Translational Sciences · ZIA · FY2023 · TR

The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment

$2,858,964
Sally Lynn Hodder · West Virginia University · U24 · FY2023 · GM

Anti NMDA Receptor antibodes in adult brain dysfunction and fetal brain development: lessons from lupus

$2,858,960
Betty Diamond · Feinstein Institute For Medical Research · P01 · FY2024 · AI